Stryker (NYSE: SYK), a global leader in medical technologies, announced today a definitive agreement to acquire all of the issued and outstanding shares of common stock of Inari Medical, Inc. (NASDAQ: ...
In patients with PAH, reducing peripheral serotonin using rodatristat ethyl negatively affects pulmonary hemodynamics and cardiac function.
Surviving a severe case of COVID-19 may be just as dangerous for your heart as having cardiovascular disease - even if you were perfectly healthy before infection.
Peripheral artery disease often leads to severe complications, including amputations, especially in those with chronic limb-threatening ischaemia. The NHS in the UK has improved its approach, reducing ...
Avinger's strategic shift comes less than a month after it said it would seek shareholder approval for a potential assignment for the benefit of creditors, followed by a voluntary dissolution and ...
Imagine putting your socks on one morning and noticing your big toe, which has been painful for a few weeks, has started ...
Multibillion-dollar buyouts returned last year, led by Johnson & Johnson’s $13.1 billion acquisition of Shockwave Medical.
Cardiovascular diseases (CVDs) are the leading cause of death worldwide, with 695,000 people dying from heart disease in the ...
FastWave Medical's technology delivers energy pulses to break up plaque in arteries caused by coronary artery disease and ...
Having cold feet and hands during winter is pretty common. While temperature is one of the factors, it is not the only one.
In conclusion, the TCW trial provides crucial insights, highlighting the potential of TAVI combined with FFR-guided PCI as a transformative, less invasive treatment for patients with severe aortic ...